Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ANGIOEDEMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01386658
What this trial is testing

A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 32
Large-scale testing (Phase 3)Study completedNCT00262288
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Genetic Disorders
Pharming Technologies B.V. 14
Not applicableEnded earlyNCT02854397
What this trial is testing

Determination of Specific Biomarkers of Acute Attack of Angioedema Within Pediatric Population

Who this might be right for
Hereditary AngioedemaHealthy Volunteers
University Hospital, Grenoble 31
Not applicableNot Yet RecruitingNCT05833620
What this trial is testing

Identification and Characterization of Genetic Variants in Hereditary Angioedema

Who this might be right for
Hereditary Angioedema With C1 Esterase Inhibitor Deficiency
Hospital Universitari Vall d'Hebron Research Institute 200
Early research (Phase 1)Ended earlyNCT00517582
What this trial is testing

Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema

Who this might be right for
Angioneurotic Edema
Vanderbilt University 13
Testing effectiveness (Phase 2)Ended earlyNCT05047185
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 34
Early research (Phase 1)Study completedNCT02663687
What this trial is testing

Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects

Who this might be right for
Hereditary Angioedema (HAE)
Shire 48
Large-scale testing (Phase 3)Study completedNCT02586805
What this trial is testing

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 125
Not applicableStudy completedNCT01034969
What this trial is testing

Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 1,761
Post-approval studies (Phase 4)Study completedNCT03576469
What this trial is testing

Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions

Who this might be right for
CVI - Common Variable Immunodeficiency
IMMUNOe Research Centers 20
Not applicableStudy completedNCT01316952
What this trial is testing

Coreg and HSRs-Updated Analysis

Who this might be right for
Hypersensitivity
GlaxoSmithKline 1
Large-scale testing (Phase 3)Looking for participantsNCT07298447
What this trial is testing

Donidalorsen Treatment in Children With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Ionis Pharmaceuticals, Inc. 20
Post-approval studies (Phase 4)Study completedNCT02966314
What this trial is testing

Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy

Who this might be right for
Idiopathic Angioedema
University of Wisconsin, Madison 12
Large-scale testing (Phase 3)Study completedNCT00262080
What this trial is testing

Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 91
Large-scale testing (Phase 3)Ended earlyNCT01275976
What this trial is testing

Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture

Who this might be right for
TraumaInflammationSepsis+1 more
UMC Utrecht 11
Not applicableStudy completedNCT00785018
What this trial is testing

In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia

Who this might be right for
EndotoxemiaInflammationMulti Organ Dysfunction Syndrome
Radboud University Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT04208412
What this trial is testing

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT05691361
What this trial is testing

Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients

Who this might be right for
Hereditary Angioedema
ADARx Pharmaceuticals, Inc. 53
Large-scale testing (Phase 3)Study completedNCT04654351
What this trial is testing

Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Takeda 2
Not applicableStudy completedNCT07611032
What this trial is testing

A Single-Arm Exploratory Study of NatureU Histra Dissolve on Chronic Urticaria Symptoms

Who this might be right for
Chronic UrticariaUrticariaAngioedema
OmniSolutions Laboratory Holdings Limited 19
Next Page